<SEC-DOCUMENT>0001213900-25-087227.txt : 20250912
<SEC-HEADER>0001213900-25-087227.hdr.sgml : 20250912
<ACCEPTANCE-DATETIME>20250912161508
ACCESSION NUMBER:		0001213900-25-087227
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250912
DATE AS OF CHANGE:		20250912

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIUS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0001851484
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				994362660
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93794
		FILM NUMBER:		251311664

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6677

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		FIRST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TenX Keane Acquisition
		DATE OF NAME CHANGE:	20210315

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Citius Pharmaceuticals, Inc. -->
          <cik>0001506251</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Shares, $0.0001 par value per share</securitiesClassTitle>
      <dateOfEvent>09/10/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001851484</issuerCIK>
        <issuerCUSIP>17331Y109</issuerCUSIP>
        <issuerName>Citius Oncology, Inc.</issuerName>
        <address>
          <com:street1>11 Commerce Drive, 1st Floor</com:street1>
          <com:city>Cranford</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07016</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Leonard L. Mazur</personName>
          <personPhoneNum>(908) 967-6677</personPhoneNum>
          <personAddress>
            <com:street1>Chief Executive Officer</com:street1>
            <com:street2>11 Commerce Drive, 1st Floor</com:street2>
            <com:city>Cranford</com:city>
            <com:stateOrCountry>NJ</com:stateOrCountry>
            <com:zipCode>07016</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Alexander M. Donaldson, Esq</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Lorna A. Knick, Esq</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Wyrick Robbins Yates &amp; Ponton</personName>
          <personPhoneNum>(919) 781-4000</personPhoneNum>
          <personAddress>
            <com:street1>4101 Lake Boone Trail, Suite 300</com:street1>
            <com:city>Raleigh</com:city>
            <com:stateOrCountry>NC</com:stateOrCountry>
            <com:zipCode>27607</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001506251</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Citius Pharmaceuticals, Inc.</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>66049615.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>66049615.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>66049615.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>79.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>CO</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Shares, $0.0001 par value per share</securityTitle>
        <issuerName>Citius Oncology, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>11 Commerce Drive, 1st Floor</com:street1>
          <com:city>Cranford</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07016</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>EXPLANATORY NOTE

On September 10, 2025, the Issuer sold and issued 5,142,858 shares of its common stock, $0.0001 par value per share, in a registered direct offering.

This Amendment No. 2 to the Schedule to the Schedule 13D of the Reporting Person filed on August 16, 2024, as amended on July 25, 2025, amends and supplements the Schedule 13D as specifically set forth herein, to give effect to the issuance of the shares on September 10, 2025.</commentText>
      </item1>
      <item5>
        <percentageOfClassSecurities>The Reporting Person is the beneficial owner of 66,049,615 shares of the Issuer's common stock, which represents approximately 79.1% of the Issuer's outstanding common stock, based upon 83,513,442 shares of common stock outstanding as of September 10, 2025.</percentageOfClassSecurities>
        <numberOfShares>The Reporting Person has sole voting and dispositive power of 66,049,615 shares of the Issuer's common stock beneficially owned.</numberOfShares>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Citius Pharmaceuticals, Inc.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Leonard Mazur</signature>
          <title>Leonard Mazur, Chief Executive Officer</title>
          <date>09/12/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
